| 000 | 01572 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250515075552.0 | ||
| 264 | 0 | _c20071004 | |
| 008 | 200710s 0 0 eng d | ||
| 022 | _a1569-9285 | ||
| 024 | 7 |
_a10.1510/icvts.2007.163386 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRaja, Shahzad G | |
| 245 | 0 | 0 |
_aDoes neoadjuvant chemotherapy improve survival in patients with resectable thoracic oesophageal cancer? _h[electronic resource] |
| 260 |
_bInteractive cardiovascular and thoracic surgery _cOct 2007 |
||
| 300 |
_a661-4 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Meta-Analysis; Review | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBenchmarking |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aEsophageal Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aEsophagectomy |
| 650 | 0 | 4 | _aEvidence-Based Medicine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoadjuvant Therapy |
| 650 | 0 | 4 | _aOdds Ratio |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 | _aProportional Hazards Models |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aSalhiyyah, Kareem | |
| 700 | 1 | _aNagarajan, Kumaresan | |
| 773 | 0 |
_tInteractive cardiovascular and thoracic surgery _gvol. 6 _gno. 5 _gp. 661-4 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1510/icvts.2007.163386 _zAvailable from publisher's website |
| 999 |
_c17203448 _d17203448 |
||